Davies Veterinary Specialists, the small animal referral hospital based at Higham Gobion in Hertfordshire, has reported treating four cases of serious lungworm (Angiostrongylus vasorum) infection over the past couple of months, all within around 30 miles of each other.
The practice says it usually sees only two or three lungworm cases a year, at most. It is thought that the increase in cases could be the result of a lack of knowledge amongst some owners about the right wormers to use, as well as the fact that lungworm appears to be getting a stronger foothold in some areas, possibly due to factors such as climate change.
One of the cases referred to DVS was a Cocker Spaniel called Honey belonging to Irené O'Hanlon-Marin from Beaconsfield. Vets initially believed the dog's symptoms of neck pain, breathlessness, shaking and lethargy to be the result of a recent head injury. Serious alarm was raised when Honey appeared to suffer a fit three weeks later, became unable to walk and lost her vision in one eye. She was immediately referred to DVS as an emergency.
Peter Smith, Neurology Specialist at DVS, said: "Honey was in a pretty serious condition when admitted here and would, I suspect, have died if she'd been left another few hours. She's now back home and much improved, and appears to be regaining her sight."
Irené O'Hanlon-Marin said: "It scares me to think how little I knew about lungworm and the fact that I need to use a specific wormer for it. We have been so lucky with Honey but I am determined to help prevent other dogs going through what she suffered so we all need to help spread the word about the dangers of this parasite."
The other three cases referred to DVS were from High Wycombe, Pinner and St Albans. The practice reports that all patients have recovered well.
The study, titled The Veterinary Employment, Engagement and Retention Study (VEER), opened this week and aims to collect data from thousands of veterinary professionals across the United Kingdom and beyond.
Dr Dermot McInerney (pictured right), VetX Head of Research and Partnerships, said: “We will use the data collected to understand the factors influencing career happiness and how they impact on talent attraction and retention.
"We want to share this information with as many people as possible so we can work together to create a better, more sustainable situation for both employers and employees in veterinary practice.”
The study findings will be published later in 2022 and made available to all industry stakeholders.
All participants will receive a special report of the results with customised career advice, and be entered into a weekly draw to win a prize.
To take part in the survey, visit: www.vetxinternational.com/veer.
Vetoquinol has made changes to Zentonil®, its liver support range for dogs and cats.
New Zentonil® is the UK's FIRST palatable and divisible tablet range of S-adenosyl-methionine (SAMe) supplementation and now comes with the added benefit of choice: Zentonil® Advanced which contains pure SAMe plus silybin and Zentonil® Plus which contains pure SAMe only.
A patent pending microencapsulation technique protects the SAMe from the harmful effects of stomach acid, even when the tablet is split or chewed.
The ability to split the tablets makes administration more accurate and also makes the product more cost-effective for clients.
Vetoquinol's new Zentonil® formulations have proven SAMe bioavailability curves in a market where this particular type of data is often lacking
Simon Boulton, product manager said: "Our customers told us that they had difficulties associated with SAMe supplementation. We have listened to their comments and provided the solutions."
The new formulations will become available as wholesalers' Zentonil® stocks are depleted. If you wish to try new Zentonil® now, you can place an order for Zentonil® Advanced or Zentonil® Plus with your wholesaler.
For more information, please contact your local Vetoquinol sales representative or telephone the free practice support number - 0800 1698197.
Ceva Animal Health UK is now providing Logic Oral Hygiene Gel sample sachets to veterinary practices free of charge, to enable clients to try before they buy on their cat or dog
In addition, to help veterinary practices promote the importance of dental hygiene, new waiting room display materials are also available.
To obtain your free Logic sample sachets or waiting room display material, please telephone 01494 781510 or e-mail customerservicesuk@ceva.com.
The case studies were developed by the RCVS Standards Committee and use a variety of examples of where miscommunication between a client and the veterinary practice can lead to an inadequate level of consent being gained for procedures and treatment, including euthanasia.
Examples include damaged teeth being removed during a clean and polish dental procedure without the owner’s express permission and not giving the full range of options available in the case of a dog with an osteosarcoma.
The case studies follow the Standards Committee approving changes to chapter 11 (‘Communication and consent’) of the supporting guidance to the RCVS Code of Professional Conduct in January 2018 to give further advice on how to discuss informed consent with clients, who can be responsible for gaining consent for a procedure and additional guidance on consent forms.
Dr Kate Richards MRCVS, Chair of the RCVS Standards Committee, said: "We hope these case studies will prove useful to practitioners who are having to deal with the complexities around making sure that procedures are fully explained to ensure informed consent is gained.
"We understand the difficulties that are encountered and so these case studies, based on real-life scenarios, highlight where things may go wrong and how these incidents can be avoided by being thorough and ensuring that good communication is at the heart of all we do."
To view the case studies, visit www.rcvs.org.uk/informed-consent.
Chapter 11 of the RCVS supporting guidance on communication and consent is available to view at www.rcvs.org.uk/consent
In the study, which was supported by MSD and led by Rosie Lyle of Bishopton Veterinary Group, 18 farmers placed temperature loggers in the fridge where they normally store vaccines. Temperatures were then monitored between February and April. Throughout this period, 89% of loggers recorded a temperature outside the 2–8°C range at least once, and 43% recorded temperatures outside this range more than 50% of the time.
The authors say that these findings raise potential concerns about vaccine efficacy.
Rosie found that 55% of the loggers recorded a temperature over 8°C, and 39% recorded a temperature below 2°C.
Across all the fridges monitored, the maximum temperature recorded was 12°C and the minimum was -11.5°C.
Rosie said: "This is a surprisingly wide range. Obviously, these findings are concerning for farmers as we know that both too high and too low temperatures can impair vaccine efficacy.
"Live vaccines tend to be particularly sensitive to elevated temperatures, whereas inactivated vaccines are more affected by freezing, especially when the adjuvant contains aluminium salts".
"It’s important for both farmers and vets to be aware of potential concerns about vaccine efficacy, given the possible impact on herd health and the potential for vaccine failure to reduce trust in vaccines and herd health recommendations".
In light of Rosie’s findings, other XLVets practices are now encouraging farmers to take action to improve medicine storage, including using max/min thermometers or temperature loggers to track fridge temperature, as well as taking steps to maximise the efficiency of each fridge.
Susan Goodfellow, Marketing Manager at XLVets, said: "We wouldn’t have known that this is an important issue to highlight to farmers without collecting the information, so Rosie’s study was very valuable.
"In the XLVets community, we support clinical leadership with these kind of projects – we actively collect data and make sure that farmers can benefit from the latest findings. As a group of independent practices working together, we can achieve much more than we could in isolation."
Emeritus Professor Leslie Vaughan DSc DVR FRCVS, President of the Royal College of Veterinary Surgeons in 1987-8, has died.
Qualifying from the Royal Veterinary College in 1949, Professor Vaughan held various posts within the RVC, including House Surgeon, Lecturer and Reader. He was awarded a personal chair in 1972 as Professor of Veterinary Orthopaedics, becoming the Professor of Veterinary Surgery and Head of Department two years later. He was Vice-Principal from 1982 to 1991.
Having formally retired in 1991, Professor Vaughan continued to see small animal orthopaedic cases referred to the Queen Mother Hospital (QMH) at the Royal Veterinary College until he finally ‘put down his scalpel' at the end of 2007. During these 16 years, not only was he involved in both undergraduate and postgraduate teaching on rotations, but claimed no payment personally for his work: he donated any fees to the RVC's Animal Care Trust to support further development of the QMH. It is fitting that the third and final phase of the QMH was opened this week by HRH the Duchess of Cornwall. This was the culmination of a major project that Professor Vaughan helped initiate in the mid-1980s.
Professor Vaughan, who was 81, became a Fellow of the RCVS in 1957 for a thesis entitled: A study of the clinical and pathological aspects of the intervertebral disc protrusion in the dog.
Dr Jerry Davies, RCVS Treasurer and former colleague of Professor Vaughan said: "Leslie Vaughan had an international reputation in veterinary orthopaedics, both as a clinician and a researcher, that included small animal, equine and even farm animal species.
"Those remarkable achievements were equalled by his skills as a teacher. He had an ability to instil in his students the fundamental principles of diagnosis where meticulous clinical observation and examination must precede the careful selection of adjunct investigations such as radiography and laboratory testing. The extraordinary number of veterinary surgeons, both past and present, that will have benefited from his teaching over no less than 58 years will never be surpassed".
The funeral will be held at St John's Church, Harpenden, Herts (http://www.stjohnsharpenden.org.uk/), at 11.30 am on Monday December 1, 2008.
Virbac is running a promotion through which practices can claim a model showing the anatomy of a healthy dog ear canal on one side, and the changes associated with chronic damage on the other.
Product Manager Chris Geddes MRCVS said: "The models are about 15cm high and provide a useful visual aid to show clients the consequences if chronic ear disease is not kept under control. They can also be used to help show clients how to administer their pet's treatment correctly.
"These models will be a useful tool for practices to help improve client compliance. Also, we know that some dog owners find a course of ear treatments tricky, and either give the wrong dose or give up altogether, which is why we designed EasOtic to dispense the exact dose in one simple 'squirt', with one complete course in each bottle".
For details of how you can obtain a model for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
NOAH Chair Gaynor Hillier said: "The production and supply of veterinary medicines is totally dependent on complex international supply chains that must continue to function effectively after Brexit, their unique status being recognised in the recent government White Paper.
"Raw materials will need to arrive at manufacturing sites and veterinary medicines will need to be transported across borders to meet market requirements. Any border delays, additional complex processes or increased costs will risk medicines availability for UK vets, farmers and all our animals."
According to a recent NOAH member survey, less than 15% of companies say they are prepared for a 'hard Brexit' with the vast majority of respondents saying they are not fully prepared should there be a reversion to WTO rules on 30 March 2019.
NOAH says this is not through lack of effort or unawareness of the need to act, but due to the magnitude of the complex tasks involved in such a specialist sector, coupled with uncertainty over what a 'no-deal' Brexit will look like.
In contrast, almost 60% of companies said they are prepared for a transition period to December 2020. Even then, NOAH says the proposed transition period will not be enough in some cases.
The survey examined product availability in the UK: almost 55% of respondents reported potential availability issues for the UK market impacting more than 40% of their products. The full spectrum of types of products (from vaccines to painkillers: from antibiotics to wormers) across all animal species (farm, equine and pet) are potentially at risk, with particular concerns raised around the supply chain for vaccines.
Eggshell membrane is rich in proteins and contains collagen type I, hyaluronic acid, chondroitin sulphate and glucosamine. Virbac says the components of eggshell membrane help to limit inflammatory processes that occur in osteoarthritis and preserve the existing cartilage structure whilst promoting synthesis. The company points to a study which showed that eggshell membrane contributes to a reduction in pain perception by 25%, improved joint function by 33% and increased quality of life by 35% within 6 weeks1.
Rémi Mandray, Product Manager at Virbac said: "I am delighted to be able to introduce this innovative new ingredient to the Veterinary HPM Joint & Mobility Clinical Diet. This is an addition to an already very comprehensive approach to nutrition in dogs with osteoarthritis, which affects 20% of the adult canine population2. Studies have shown that improvement on mobility is visible as quickly as 2 weeks after diet introduction3 – changing their diet truly can change their life!’
For more information contact your Virbac Territory Manager.
Reference
The project, which has been supported by Zoetis, came about after 45 vets from 35 CVS practices identified osteoarthritis (OA) as the main clinical area their practice team wanted to develop over the next 18 months.
As a result, the VOA and CVS came together and signed a Memorandum of Understanding under which the VOA will support CVS with training, resources and research.
The goal is to improve the care of OA patients by engaging the whole practice team and clients in their pets’ care.
Professor Stuart Carmichael, VOA Director said: “VOA’s aim is to provide access to the latest research, evidence and technologies and facilitate a multi-professional collaboration supporting practices wishing to improve their management of osteoarthritis.
CVS practices participating in this project will become eligible for accreditation by the VOA in recognition of the training they've undergone.
As the project develops, CVS says it will assess the results of the initiative, learning more about strategies that can improve and enhance management of OA.
This should translate into the development of better long-term approaches for the management of OA that can be used across the profession.
Meantime, the Veterinary Osteoarthritis Alliance (VOA) has a practice accreditation scheme which is available to any practice which is looking to improve its management of OA.
Further information is available at: vet-oa.com
The ISFM says Congress will offer veterinary professionals an extensive scientific programme designed to support a multi-modal and cat friendly approach to caring for feline patients with acute upper urinary tract disease and other emergencies.
Speakers will include Søren Boysen (Emergency & Critical Care), Serge Chalhoub (Internal Medicine), Laura Owen (Soft Tissue Surgery) and special guest Allyson Berent (Non-Invasive Surgery).
Sam Taylor MRCVS, ISFM Veterinary Specialist Lead (pictured right) said: "We seem to be seeing more and more feline urinary cases, urolithiasis and acute kidney injury - and of course the familiar blocked cats!
"In Dublin, I can’t wait to hear how to approach these cases as well as look more in-depth at ECC and discuss cat friendly critical care amongst many other topics from all angles – surgery, medicine, behaviour, imaging and more!’
The 2023 ISFM Feline Congress Dublin is open to veterinary surgeons and nurses of all experience levels.
https://icatcare.org/congress-2023-dublin/
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
The RCVS has published new guidance for veterinary surgeons on 24-hour emergency first aid and pain relief, providing greater definition of the professional and legal responsibilities of veterinary surgeons in the provision of emergency care, as well as owners' responsibilities for their animals.
Two sections of the supporting guidance to the Code of Professional Conduct have been updated - Chapter 2 'Veterinary care' and Chapter 3 '24-hour emergency first aid and pain relief' - placing a greater emphasis on owners' legal responsibilities for their animals while obligating veterinary surgeons to provide full details of their 24-hour emergency cover provision to clients.
Although veterinary surgeons are professionally obliged to take steps to provide 24-hour emergency first aid and pain relief, the new supporting guidance clarifies situations where delaying or declining attendance to an animal may be appropriate. It is hoped this will assist and empower vets to decline to attend an animal away from practice where they feel it is unnecessary or unsafe.
The changes are the culmination of an evidence-gathering process with both members of the profession and animal owners about each group's expectations around the provision of 24-hour emergency care.
This process began with a call for evidence at the end of 2013, which garnered some 656 pages of written evidence, as well as a petition on home visits with over 2,800 signatures. Following this, in March 2014 there was a three-day hearing in which 15 organisations and 10 individuals were invited to attend to give evidence to the RCVS Standards Committee. Also taken into account were more than 1,000 responses from veterinary surgeons taking part in the Survey of the Professions and an online survey with 1,250 animal owners.
After a thorough review of the evidence the Standards Committee developed the new supporting guidance, which was agreed in principle by RCVS Council in its June meeting.
Gordon Hockey, RCVS Registrar, said: "Following the considerable disquiet within the profession following the Disciplinary Committee's decision on the Chikosi hearing in June 2013, we decided that only a thorough evidence-gathering process with all parties could resolve the apparent gap between the expectation of the public regarding 24-hour emergency care and the profession's ability to meet this.
"We are very happy with the way that this process was carried out and would like to thank the many individual veterinary surgeons and animal owners, as well as representative organisations, who have contributed to this outcome.
"By making the legal and professional obligations of veterinary surgeons and the welfare obligations of animal owners clearer we hope that this new guidance should allay some of the frustrations and concerns of the profession."
The new supporting guidance for Chapter 3 '24-hour emergency first aid and pain relief' can be viewed at www.rcvs.org.uk/247care, while the additional guidance for Chapter 2 'Veterinary care' can be viewed at www.rcvs.org.uk/vetcare
A webinar in which Gordon Hockey and Clare Tapsfield-Wright, former Chairman of Standards Committee, explain the guidance in greater detail takes place at 8.30pm tonight.
Visit www.thewebinarvet.com/rcvs to register.
The RCVS issued a reminder today that there is just over a month left before the 1 April deadline for all veterinary practice premises from which medicines are to be supplied to be registered with the College.
Just over 4,500 premises have applied for registration since November 2008. This includes about 750 premises not previously listed with the College, demonstrating the usefulness of the process, which will enable the government to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines.
From 1 April it will be an offence for a veterinary surgeon to supply a veterinary medicinal product from any practice premises not registered with the RCVS. On conviction, those committing the offence may be liable to prosecution, which may include a fine or prison sentence. Veterinary surgeons convicted of criminal offences are also considered by the College's Preliminary Investigation Committee to decide whether the conviction would affect the individual's fitness to practise and should be referred to the Disciplinary Committee.
In addition to ensuring their practice premises are registered, veterinary surgeons also need to keep a record of other places where medicines are stored, so these can be considered during an inspection - such as vets' homes or cars, or perhaps a charity premises from which veterinary work is carried out and where medicines are stored. Such records will not be published, although some of those premises may need to be registered in their own right.
Practices accredited under the RCVS Practice Standards Scheme will be inspected by the RCVS; non-compliance with medicines standards will be dealt with under the rules of the Scheme. The Veterinary Medicines Directorate (VMD) will carry out inspections of other registered premises to ensure compliance with the Veterinary Medicines Regulations. Where non-compliance is noted, the VMD will take a proportionate enforcement approach ranging from issuing advice to, where appropriate, serving an improvement notice or seizing medicines.
The Veterinary Benevolent Fund (VBF) has announced the retirement of its President Dr. Lydia Brown, who had served the maximum of nine years as a trustee and member of the VBF Board.
Lydia became a director of the VBF following the merger of the Fund with the Vet Helpline (VHL) and the Veterinary Surgeons' Health Support Programme (VSHSP) in January 2005.
A past-president of the Royal College of Veterinary Surgeons (RCVS) and former chairman of the RCVS Trust, Lydia was a driving force behind the establishment of the VSHSP in 1999. This support programme was developed in response to the genuine need for a confidential service to treat veterinary surgeons with a wide variety of addictive conditions. Since then she has been involved in the expansion of the Helpline service from a telephone service to an increasingly-widely used email service.
The charity says that it is as a result of Lydia's thoroughness, sympathy and understanding, that very many veterinary surgeons and veterinary nurses have been helped to recover from many forms of addictive conditions and health problems.
Petplan has announced the finalists for the 2012 Petplan Veterinary Awards.
According to the company, the awards have been more popular than ever, with over 3,000 nominations submitted for exceptional veterinary staff across the UK.
The finalists for each of the categories are:
Vet of the YearZaila Dunbar, Queens Park Veterinary Practice - London Tony Barnes, Manor Veterinary Clinic - FolkestoneMark Taylor, Feldon Veterinary Centre - Bedworth
Vet Nurse of the YearLucy Kells, The Wildlife Aid Foundation - LeatherheadRachael Harris, Elms Veterinary Surgery - MonmouthSarah Algar, Brentknoll Veterinary Centre Ltd - Worcester
Support Staff of the YearSarah Bowler, Holly House Veterinary Surgery - KnutsfordJane Wyatt, George Hunt and Son - PoyntonCathy Campbell, Haygate Veterinary Centre - Telford
Vet Practice of the YearEastcott Veterinary Clinic and Hospital - SwindonPrince Bishop Veterinary Hospital - County DurhamBroadleys Veterinary Hospital - Stirling
Simon Masding, Petplan's Head of Sales and Partnerships, said: "The Vet of the Year Awards are the highlight of our Petplan calendar because they recognise the dedication that the veterinary industry puts into providing the nation's pets with the best possible treatment. Each year the nominations reach an even higher standard and we're delighted with this year's finalists. At Petplan we work with more veterinary professionals than any other insurance provider and it is through these awards that we thank the profession on behalf of UK pet owners."
Petplan has also announced that comedian Seann Walsh, known for his appearances on shows like Mock the Week and Michael McIntyre's Comedy Roadshow, will be this year's compère for the Vet of the Year Awards. Following in the footsteps of previous compères Michael McIntyre, Alistair McGowan, Frankie Boyle and Jason Manford; he will be entertaining this year's guests on the 12th April at Birmingham Town Hall.
For further information visit www.petplan.co.uk/vetawards/
The ophthalmology service, which offers cataract surgery, corrective eyelid surgery and corneal disease management amongst other things, is headed by RCVS and US Ophthalmology Specialist, James Histed (pictured right)
The hospital, which has doubled in size to 30,000ft², now has a purpose-built theatre complex, a new reception and waiting area, 12 additional consulting rooms and a new rehabilitation centre equipped with a water treadmill and a large arena for treatment and gait analysis.
It also has a new lecture theatre where SCVS can deliver its CPD programme and parent company IVC can deliver its intern and residency programme.
The company says that its redevelopment has focused on employee wellbeing, to which end there is a new staff area for the 200-strong team a place to gather, dine and relax.
Kennel space for staff dogs has also been increased to support SCVS’s ‘bring your dog to work’ policy.
The new hospital facility is fully operational and open 24/7 for referrals, supporting colleagues from surrounding vet practices.
www.scvetspecialists.co.uk
VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
Janssen Animal Health has announced that it has acquired the distribution rights for a range of sedatives and anaesthetics for small and large animals, including Dexdomitor, Domitor and Antisedan.
Janssen aquired the marketing and distribution rights, which were previously held by Pfizer Inc, from Orion Corporation.
Dr. Enno Gottschalk , Janssen's European Director Marketing and Sales said: "This acquisition of distribution rights results in the perfect combination of proven and effective products with the outstanding service and technical selling capabilities of Janssen Animal Health. The products include the sedative Dexdomitor and Domitor, as well as the antagonist Antisedan. Among large animals, predominantly horses, the sedative injection Domosedan is now on offer as part of the Janssen Animal Health portfolio."
Until the arrival of Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), radiographs were the only feasible option. More recently, the availability of bigger, wider and more adaptable scanners has allowed horses to be examined in a standing position, significantly improving diagnostic and treatment strategies and avoiding the need for general anaesthetic.
Against this background the collection considers the advantages of cutting-edge modalities and draws comparisons with more readily available tools such as radiography.
Given the increase in use of CT in horses and the contamination hazards faced particularly by horse handlers, two practical articles in the collection describe the role of equine head CT, how to set up standing equine CT and the radiation exposure risks.1,2
The most revolutionary recent advance in diagnostic imaging for dental disease in horses is CT. However, a study of horses with diseased mandibular cheek teeth found that while CT is useful to identify defects in the bone and tooth it is far less useful for the identification of inflammation and tissue destruction which is far better served by MRI.3
The structure of the equine head is complex and subject to great variation so several articles focus on practical anatomy and interpretation of radiographs of this region.4.5 Advanced diagnostic techniques are helping with clinical and surgical approaches to problems with the equine head. The sphenopalatine sinus is challenging to assess radiographically because of its tricky position but CT can help overcome this obstacle. One of the studies describes how CT can help unravel the pathology of various equine sinonasal tumours. Other articles cover less common pathological conditions including the historical, clinical, diagnostic imaging findings and outcomes of five horses with pneumocephalus. 6,7,8
Practitioners recognise MRI as the gold standard for neurologic imaging because of the excellent soft tissue detail but the size of horses and the size of scanners makes it a challenge to use. An additional constraint is the longer acquisition time compared to CT. Notwithstanding these limitations three studies in the collection display the various benefits of using MRI for the spine and neck, including the evaluation of 84 equine head disorders, the diagnosis of cervical stenotic myelopathy, and the assessment of two foals with closed head trauma.9,10,11,12
Despite the significant advances in imaging, the horse’s back is still defying conventional systems, primarily because of its size, concludes a spinal evaluation article. New technologies such as robotic fluoroscopy and cone-beam CT, may provide a cross-sectional method to evaluate the equine spine, but for now radiographs are still better to help evaluate findings of spinous process impingement seen on scintigraphy. The take home message here is that the wide variety of abnormalities seen on scintigraphy and radiography in horses with and without back pain makes a diagnosis more likely to be achieved by physical examination rather than the imaging findings.13
Anthony Pease, associate editor of the EVJ said: "Advanced imaging is still in its infancy with sequences still being developed to help optimise the time and detail needed for diagnosing complex musculoskeletal and neurologic disorders. Continued research in a controlled environment and comparing to histopathology will allow clinicians to further their knowledge and understanding of the CT and MRI findings in the equine patients."
References
"We are urgently looking at what these new national lockdowns will mean for veterinary professionals and services, and we are liaising with the Chief Veterinary Officers.
"We aim to issue updated guidance in the coming days but can confirm that we will not be reverting to emergency-only work, as we saw at the start of the first UK-wide lockdown last March.
"Instead, we are developing guidance to support veterinary professionals to carry out work that is essential for public health and animal health and welfare, in the context of the very strong ‘stay at home’ messages from both governments.
"We recognise that this continues to be a very challenging and difficult time for our colleagues, and we want to thank veterinary teams across the UK for continuing to work safely so that we can all play our part in stopping the spread of Covid.
"Once again we thank animal owners for their understanding and ask them to continue to respect their vets’ decisions at this time. The range of services available will vary between practices so that vets can work in Covid-safe ways to keep their colleagues and clients safe."
The charity says it estimates there has been a ten-fold increase in fertility clinics in the past two years, and it is now aware of at least 339 dog fertility businesses across the UK.
Such clinics, which typically offer artificial insemination, progesterone testing, cytology and ultrasound scanning, are often operated by lay people, rather than veterinary professionals.
There have been concerns about the seeming indiscriminate use of breeding procedures by some fertility clinics, and about links to low welfare breeding operations.
Naturewatch says some fertility clinics have been found selling and administering prescription medicines and offering to perform operations.
The charity now wants to understand what veterinary professionals think about this new industry, and is running a short survey until 21st August 2022.
In particular, Naturewatch wants to know who you think should be permitted to perform commonly offered breeding procedures.
It also wants to hear your thoughts about possible solutions.
Are canine fertility clinics inherently problematic?
Or could canine fertility clinics - if operated ethically and regulated properly - bridge the gap between breeders and the veterinary profession?
Complete the survey here: https://action.naturewatch.org/canine-fertility-clinic-survey-for-veterinary-professionals
The materials available include a scour management guide for farmers and a more detailed version for vets. They encourage a focus on three main areas for improved, sustained disease control: maximising calf immunity; identifying any causal agents and how to effectively manage an outbreak of calf scour on farm.
MSD Animal Health veterinary adviser Dr Kat Baxter-Smith (pictured right) said: "Even with good disease prevention protocols in place, calf scour outbreaks can still occur. But when they do, remedial action should focus on these three key areas to resolve the outbreak as quickly as possible and reduce the chances of another costly event happening in the future.
The company highlights a 202 survey of more than 300 farms, which found that over 80% of UK calf rearing units had seen a case of scour in the previous 12 months; with 50% of farms admitting to experiencing calf deaths due to the disease1. Costs are estimated at £57.94 per case but this does not include the longer-term impacts of the disease on future calf productivity.2,3
Merial has announced that a recent change of licence means you can now administer the new generation NSAID, Previcox® for the relief of post operative pain associated with soft tissue and orthopaedic surgery in dogs.
Mark Riggs MRCVS, Veterinary Technical Advisor for Merial said: "Previcox (firocoxib) is now licensed for the relief of post operative pain. Oral PREVICOX can be administered starting 2 hours prior to surgery and has a rapid onset of action reaching peak plasma levels within 90 minutes. The palatable tablet can be given without food and is a realistic option which should be seriously considered when choosing pain relief for surgical patients.
"Containing the active ingredient firocoxib, Previcox is also highly COX-2 selective, being 380 times more selective for COX-2 than COX-1. As a result, it offers a highly desirable efficacy and safety profile which is particularly beneficial in cases which have gone through the additional stress of surgery.
"The recently published study by John P. Punke et al strengthens the evidence reinforcing the benefits offered by firocoxib. The research evaluated the in-vivo effects of firocoxib, meloxicam and tepoxalin in target tissues of dogs suffering with chronic osteoarthritis.
"Eight dogs were used in the cross-over study and each dog received each of the treatments (and a placebo) for seven days, with an appropriate wash out period in between. Firocoxib significantly reduced inflammatory mediators within blood and synovial fluid at all time points, whereas meloxicam only showed a significant reduction compared to baseline values at day four.
"With evidence demonstrating the speed of the anti-inflammatory effect of firocoxib, it may be time for vets to reconsider their post operative pain management. Previcox can be administered orally prior to surgery and can be given once daily for up to three days post operatively. For orthopaedic surgery this treatment schedule can be extended after the first 3 days upon judgement of the attending vet."
For further information please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.